STAT+: Pharmalittle: We’re reading about Trump’s MFN deals, 340B program controversies, and much more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines,...